loadpatents
name:-0.005836009979248
name:-0.0058190822601318
name:-0.0013308525085449
Beaubien; Sylvie Patent Filings

Beaubien; Sylvie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beaubien; Sylvie.The latest application filed is for "intermediates for macrocyclic compounds".

Company Profile
0.13.13
  • Beaubien; Sylvie - Sherbrooke CA
  • Beaubien; Sylvie - Quebec N/A CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Intermediates for macrocyclic compounds
Grant 10,040,751 - Marsault , et al. August 7, 2
2018-08-07
Intermediates For Macrocyclic Compounds
App 20160221927 - Marsault; Eric ;   et al.
2016-08-04
Intermediates for macrocyclic compounds
Grant 9,181,298 - Marsault , et al. November 10, 2
2015-11-10
Spatially-defined macrocycles incorporating peptide bond surrogates
Grant 8,557,765 - Deslongchamps , et al. October 15, 2
2013-10-15
Processes for intermediates for macrocyclic compounds
Grant 8,497,242 - Marsault , et al. July 30, 2
2013-07-30
Spatially-defined macrocyclic compounds useful for drug discovery
Grant 8,440,851 - Marsault , et al. May 14, 2
2013-05-14
Macrocyclic Inhibitors Of Serine Protease Enzymes
App 20120270807 - Marsault; Eric ;   et al.
2012-10-25
Methods Of Using Macrocyclic Inhibitors Of Serine Protease Enzymes
App 20120270769 - Marsault; Eric ;   et al.
2012-10-25
Processes for Intermediates for Macrocyclic Compounds
App 20110245459 - Marsault; Eric ;   et al.
2011-10-06
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery
App 20110237785 - Marsault; Eric ;   et al.
2011-09-29
Spatially-defined macrocyclic compounds useful for drug discovery
Grant 8,022,252 - Deslongchamps , et al. September 20, 2
2011-09-20
Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same
App 20110105389 - Hoveyda; Hamid R. ;   et al.
2011-05-05
Spatially-defined Macrocycles Incorporating Peptide Bond Surrogates
App 20090312540 - Deslongchamps; Pierre ;   et al.
2009-12-17
Intermediates For Macrocyclic Compounds
App 20090240027 - Marsault; Eric ;   et al.
2009-09-24
Macrocyclic Modulators of the Ghrelin Receptor
App 20090198050 - Marsault; Eric ;   et al.
2009-08-06
Spatially-defined macrocycles incorporating peptide bond surrogates
Grant 7,550,431 - Deslongchamps , et al. June 23, 2
2009-06-23
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery
App 20090137817 - Deslongchamps; Pierre ;   et al.
2009-05-28
Macrocyclic antagonists of the motilin receptor
Grant 7,521,420 - Fraser , et al. April 21, 2
2009-04-21
Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
Grant 7,452,862 - Deslongchamps , et al. November 18, 2
2008-11-18
Spatially-defined macrocyclic compounds useful for drug discovery
App 20050137127 - Deslongchamps, Pierre ;   et al.
2005-06-23
Spatially-defined macrocycles incorporating peptide bond surrogates
App 20050119169 - Deslongchamps, Pierre ;   et al.
2005-06-02
Macrocyclic antagonists of the motilin receptor
App 20050054562 - Fraser, Graeme ;   et al.
2005-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed